Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

S Wang, R Zhu, C Zhang, Y Guo, M Lv, C Zhang… - Plos one, 2023 - journals.plos.org
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in
patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients …

Preexisting coronary artery disease among coronavirus disease 2019 patients: a systematic review and meta-analysis

M Zuin, G Rigatelli, C Bilato, A Rigatelli… - Journal of …, 2022 - journals.lww.com
Aims The prevalence and prognostic implications of coronary artery disease (CAD) in
patients infected by the novel coronavirus 2019 (COVID-19) disease remain unclear …

Coronary heart disease and COVID-19: A meta-analysis

C Liang, W Zhang, S Li, G Qin - Medicina Clínica (English Edition), 2021 - Elsevier
Abstract Objective Since the World Health Organization (WHO) announced coronavirus
disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number …

[HTML][HTML] Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis

F Alzoughool, S Abumweis, M Atoum - Osong public health and …, 2022 - ncbi.nlm.nih.gov
Objectives The aim of this study was to evaluate the association of pre-existing
cardiovascular comorbidities, including hypertension and coronary heart disease, with …

Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis

G Aggarwal, I Cheruiyot, S Aggarwal, J Wong… - Current problems in …, 2020 - Elsevier
Observational studies have reported an association between underlying cardiovascular
diseases (CVD) and worse prognosis in COVID-19 patients, but this still remains unclear …

History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case–control study

T Gu, Q Chu, Z Yu, B Fa, A Li, L Xu, R Wu, Y He - BMJ open, 2020 - bmjopen.bmj.com
Objective Evaluate the risk of pre-existing comorbidities on COVID-19 mortality, and provide
clinical suggestions accordingly. Setting A nested case–control design using confirmed case …

Effect of coronary artery disease on COVID-19—prognosis and risk assessment: a systematic review and meta-analysis

L Szarpak, M Mierzejewska, J Jurek, A Kochanowska… - Biology, 2022 - mdpi.com
Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …

[HTML][HTML] Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease

MM Kerolos, M Ruge, A Gill, MI Planek… - American Heart Journal …, 2022 - Elsevier
Introduction Patients with pre-existing cardiovascular disease may carry a higher risk for
mortality from COVID-19. This study examined the association between individuals with pre …

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis

P Ssentongo, AE Ssentongo, ES Heilbrunn, DM Ba… - PloS one, 2020 - journals.plos.org
Background Estimating the risk of pre-existing comorbidities on coronavirus disease 2019
(COVID-19) mortality may promote the importance of targeting populations at risk to improve …

[HTML][HTML] The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis

K Matsushita, N Ding, M Kou, X Hu, M Chen, Y Gao… - Global …, 2020 - ncbi.nlm.nih.gov
Background: Whether cardiovascular disease (CVD) and its traditional risk factors predict
severe coronavirus disease 2019 (COVID-19) is uncertain, in part, because of potential …